BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35349875)

  • 1. The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals.
    Ekram ARMS; Woods RL; Ryan J; Espinoza SE; Gilmartin-Thomas JFM; Shah RC; Mehta R; Kochar B; Lowthian JA; Lockery J; Orchard S; Nelson M; Fravel MA; Liew D; Ernst ME
    Arch Gerontol Geriatr; 2022; 101():104694. PubMed ID: 35349875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association between Frailty and Dementia-Free and Physical Disability-Free Survival in Community-Dwelling Older Adults.
    Ekram ARMS; Ryan J; Espinoza SE; Newman AB; Murray AM; Orchard SG; Fitzgerald SM; McNeil JJ; Ernst ME; Woods RL
    Gerontology; 2023; 69(5):549-560. PubMed ID: 36617406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association between Metabolic Syndrome, Frailty and Disability-Free Survival in Healthy Community-dwelling Older Adults.
    Saifuddin Ekram ARM; Espinoza SE; Ernst ME; Ryan J; Beilin L; Stocks NP; Ward SA; McNeil JJ; Shah RC; Woods RL
    J Nutr Health Aging; 2023; 27(1):1-9. PubMed ID: 36651481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study.
    Alqahtani B
    Front Public Health; 2023; 11():1148671. PubMed ID: 37304087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly Study.
    Espinoza SE; Woods RL; Ekram ARMS; Ernst ME; Polekhina G; Wolfe R; Shah RC; Ward SA; Storey E; Nelson MR; Reid CM; Lockery JE; Orchard SG; Trevaks R; Fitzgerald SM; Stocks NP; Chan A; McNeil JJ; Murray AM; Newman AB; Ryan J
    J Gerontol A Biol Sci Med Sci; 2022 Oct; 77(10):2007-2014. PubMed ID: 34758073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between frailty and incident cardiovascular disease events in community-dwelling healthy older adults.
    Ekram ARMS; Tonkin AM; Ryan J; Beilin L; Ernst ME; Espinoza SE; McNeil JJ; Nelson MR; Reid CM; Newman AB; Woods RL
    Am Heart J Plus; 2023 Apr; 28():. PubMed ID: 37168270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication exposure and frailty in older community-dwelling patients: a cross-sectional study.
    Reallon E; Chavent B; Gervais F; Dauphinot V; Vernaudon J; Krolak-Salmon P; Mouchoux C; Novais T
    Int J Clin Pharm; 2020 Apr; 42(2):508-514. PubMed ID: 32140916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fried phenotype of frailty: cross-sectional comparison of three frailty stages on various health domains.
    Op het Veld LP; van Rossum E; Kempen GI; de Vet HC; Hajema K; Beurskens AJ
    BMC Geriatr; 2015 Jul; 15():77. PubMed ID: 26155837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of allopurinol with persistent physical disability and frailty in a large community based older cohort.
    Zhou Z; Ryan J; Nelson MR; Woods RL; Orchard SG; Zhu C; Gilmartin-Thomas JFM; Fravel MA; Owen AJ; Murray AM; Espinoza SE; Ernst ME
    J Am Geriatr Soc; 2023 Sep; 71(9):2798-2809. PubMed ID: 37158186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
    Porter B; Arthur A; Savva GM
    BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults.
    Nishiguchi S; Yamada M; Fukutani N; Adachi D; Tashiro Y; Hotta T; Morino S; Shirooka H; Nozaki Y; Hirata H; Yamaguchi M; Arai H; Tsuboyama T; Aoyama T
    J Am Med Dir Assoc; 2015 Feb; 16(2):120-4. PubMed ID: 25244957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frailty Status and Polypharmacy Predict All-Cause Mortality in Community Dwelling Older Adults in Europe.
    Midão L; Brochado P; Almada M; Duarte M; Paúl C; Costa E
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33808273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free Survival.
    Ryan J; Espinoza S; Ernst ME; Ekram ARMS; Wolfe R; Murray AM; Shah RC; Orchard SG; Fitzgerald S; Beilin LJ; Ward SA; Williamson JD; Newman AB; McNeil JJ; Woods RL
    J Gerontol A Biol Sci Med Sci; 2022 Jan; 77(1):19-26. PubMed ID: 34338761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of prescription and non-prescription polypharmacy by frailty and sex among middle-aged and older Canadians.
    Harris DA; Guo Y; Nakhla N; Tadrous M; Hogan DB; Hennessy D; Langlois K; Garner R; Leslie S; Bronskill SE; Heckman G; Maxwell CJ
    Health Rep; 2022 Jun; 33(6):3-16. PubMed ID: 35876612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Reported Hearing Impairment and Incident Frailty in English Community-Dwelling Older Adults: A 4-Year Follow-Up Study.
    Liljas AEM; Carvalho LA; Papachristou E; Oliveira C; Wannamethee SG; Ramsay SE; Walters K
    J Am Geriatr Soc; 2017 May; 65(5):958-965. PubMed ID: 27991672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study.
    Veronese N; Stubbs B; Noale M; Solmi M; Pilotto A; Vaona A; Demurtas J; Mueller C; Huntley J; Crepaldi G; Maggi S
    J Am Med Dir Assoc; 2017 Jul; 18(7):624-628. PubMed ID: 28396180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy at discharge in older hospitalised patients in Vietnam and its association with frailty.
    Nguyen TX; Nguyen TN; Nguyen AT; Nguyen HTT; Nguyen TTH; Nguyen TN; Pham T; Vu HTT
    Australas J Ageing; 2020 Sep; 39(3):230-236. PubMed ID: 31677221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study.
    Saum KU; Schöttker B; Meid AD; Holleczek B; Haefeli WE; Hauer K; Brenner H
    J Am Geriatr Soc; 2017 Feb; 65(2):e27-e32. PubMed ID: 28024089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frailty, Polypharmacy, and Health Outcomes in Older Adults: The Frailty and Dependence in Albacete Study.
    Bonaga B; Sánchez-Jurado PM; Martínez-Reig M; Ariza G; Rodríguez-Mañas L; Gnjidic D; Salvador T; Abizanda P
    J Am Med Dir Assoc; 2018 Jan; 19(1):46-52. PubMed ID: 28899661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: similarities and discrepancies.
    Mijnarends DM; Schols JM; Meijers JM; Tan FE; Verlaan S; Luiking YC; Morley JE; Halfens RJ
    J Am Med Dir Assoc; 2015 Apr; 16(4):301-8. PubMed ID: 25530211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.